Abstract:Engineered myoglobins have recently emerged as promising scaffolds for catalyzing carbene-mediated transformations. In this work, we investigated the effect of altering the metal center and its first-sphere coordination environment on the carbene transfer reactivity of myoglobin. To this end, we first established an efficient protocol for the recombinant expression of myoglobin variants incorporating metalloporphyrins with non-native metals, including second- and third-row transition metals (ruthenium, rhodium… Show more
“…In agreement with previous observations, 9 the presence of oxygen significantly reduces the catalytic activity of Mb(H64V,V68A), which exhibits only ~430 TON for the formation of 5 (Entry 3, Table 1) compared to >10,000 TON 6a under oxygen-free conditions. The stereoselectivity of the transformation is also affected (98% de and 95% ee vs. >99.9% de and ee ).…”
supporting
confidence: 92%
“…6a Since ferrous myoglobin has high affinity for oxygen, this non-native reactivity is severely suppressed in the presence of air, imposing the need for strictly anaerobic conditions to realize these transformations. While this inhibitory effect is somewhat alleviated by mutations at the level of the distal histidine residue, 9 which is directly involved in stabilizing the oxy-form of myoglobin, 10 the catalytic activity of Mb-based cyclopropanation catalysts is drastically reduced in the presence of oxygen. A similar drawback concerns iron-porphyrins and other synthetic iron-based catalysts previously investigated for cyclopropanation reactions.…”
Myoglobin has recently emerged as a promising biocatalyst for catalyzing carbene-mediated cyclopropanation, a synthetically valuable transformation not found in nature. Having naturally evolved for binding dioxygen, the carbene transferase activity of this metalloprotein is severely inhibited by it, imposing the need for strictly anaerobic conditions to conduct these reactions. In this report, we describe how substitution of the native heme cofactor with an iron-chlorin e6 complex enabled the development of a biocatalyst capable of promoting the cyclopropanation of vinylarenes with high catalytic efficiency (up to 6,970 TON), turnover rate (>2,000 turnovers/min), and stereoselectivity (up to 99% de and ee) in the presence of oxygen. The artificial metalloenzyme can be recombinantly expressed in bacterial cells, enabling its application also in the context of whole-cell biotransformations. This work makes available a robust and easy-to-use oxygen-tolerant biocatalyst for asymmetric cyclopropanations and demonstrates the value of porphyrin ligand substitution as a strategy for tuning and enhancing the catalytic properties of hemoproteins in the context of abiological reactions.
“…In agreement with previous observations, 9 the presence of oxygen significantly reduces the catalytic activity of Mb(H64V,V68A), which exhibits only ~430 TON for the formation of 5 (Entry 3, Table 1) compared to >10,000 TON 6a under oxygen-free conditions. The stereoselectivity of the transformation is also affected (98% de and 95% ee vs. >99.9% de and ee ).…”
supporting
confidence: 92%
“…6a Since ferrous myoglobin has high affinity for oxygen, this non-native reactivity is severely suppressed in the presence of air, imposing the need for strictly anaerobic conditions to realize these transformations. While this inhibitory effect is somewhat alleviated by mutations at the level of the distal histidine residue, 9 which is directly involved in stabilizing the oxy-form of myoglobin, 10 the catalytic activity of Mb-based cyclopropanation catalysts is drastically reduced in the presence of oxygen. A similar drawback concerns iron-porphyrins and other synthetic iron-based catalysts previously investigated for cyclopropanation reactions.…”
Myoglobin has recently emerged as a promising biocatalyst for catalyzing carbene-mediated cyclopropanation, a synthetically valuable transformation not found in nature. Having naturally evolved for binding dioxygen, the carbene transferase activity of this metalloprotein is severely inhibited by it, imposing the need for strictly anaerobic conditions to conduct these reactions. In this report, we describe how substitution of the native heme cofactor with an iron-chlorin e6 complex enabled the development of a biocatalyst capable of promoting the cyclopropanation of vinylarenes with high catalytic efficiency (up to 6,970 TON), turnover rate (>2,000 turnovers/min), and stereoselectivity (up to 99% de and ee) in the presence of oxygen. The artificial metalloenzyme can be recombinantly expressed in bacterial cells, enabling its application also in the context of whole-cell biotransformations. This work makes available a robust and easy-to-use oxygen-tolerant biocatalyst for asymmetric cyclopropanations and demonstrates the value of porphyrin ligand substitution as a strategy for tuning and enhancing the catalytic properties of hemoproteins in the context of abiological reactions.
“…demonstrated that Mb variants incorporating a non-natural Mn- or Co-porphyrin IX cofactor catalyze intramolecular C–H amination reactions with sulfonyl azides, with reactivities comparable to their iron-containing counterpart [19]. This work was recently expanded by Sreenilayam et al , who reported the recombinant expression of Mb variants incorporating various first, second and third row transition metal cofactors (Mn, Co, Ru, Rh, Ir) [31]. The resulting Mb variants were catalytically active in cyclopropanation, N-H and S-H insertion reactions albeit with generally reduced efficiency compared to the iron-containing counterparts.…”
Section: New Carbene Transfer Reactions Catalyzed By Engineered Heme mentioning
The surge in reports of heme-dependent proteins as catalysts for abiotic, synthetically valuable carbene and nitrene transfer reactions dramatically illustrates the evolvability of the protein world and our nascent ability to exploit that for new enzyme chemistry. We highlight the latest additions to the hemoprotein-catalyzed reaction repertoire (including carbene Si–H and C–H insertions, Doyle-Kirmse reactions, aldehyde olefinations, azide-to-aldehyde conversions, and intermolecular nitrene C–H insertion) and show how different hemoprotein scaffolds offer varied reactivity and selectivity. Preparative-scale syntheses of pharmaceutically relevant compounds accomplished with these new catalysts are beginning to demonstrate their biotechnological relevance. Insights into the determinants of enzyme lifetime and product yield are providing generalizable cues for engineering heme-dependent proteins to further broaden the scope and utility of these non-natural activities.
“…These enzymes have proven amenable to optimization by both genetic methods and co‐factor replacement 14, 15, 16, 17, 18, 19, 20. A common feature of these (designed) heme enzymes is that they contain a large hydrophobic substrate binding pocket orthogonal to the plane of the heme moiety.…”
An artificial heme enzyme was created through self‐assembly from hemin and the lactococcal multidrug resistance regulator (LmrR). The crystal structure shows the heme bound inside the hydrophobic pore of the protein, where it appears inaccessible for substrates. However, good catalytic activity and moderate enantioselectivity was observed in an abiological cyclopropanation reaction. We propose that the dynamic nature of the structure of the LmrR protein is key to the observed activity. This was supported by molecular dynamics simulations, which showed transient formation of opened conformations that allow the binding of substrates and the formation of pre‐catalytic structures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.